Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1989 1
1993 5
1994 7
1995 1
1996 2
1997 4
1998 4
1999 5
2000 7
2001 3
2002 1
2003 7
2004 5
2005 8
2006 7
2007 6
2008 13
2009 8
2010 12
2011 10
2012 10
2013 9
2014 7
2015 5
2016 7
2017 9
2018 4
2019 11
2020 13
2021 10
2022 14
2023 10
2024 16
2025 21
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Results by year

Filters applied: . Clear all
Page 1
Myasthenia Gravis.
Gilhus NE. Gilhus NE. N Engl J Med. 2016 Dec 29;375(26):2570-2581. doi: 10.1056/NEJMra1602678. N Engl J Med. 2016. PMID: 28029925 Review. No abstract available.
Myasthenia gravis-Pathophysiology, diagnosis, and treatment.
Tannemaat MR, Huijbers MG, Verschuuren JJGM. Tannemaat MR, et al. Handb Clin Neurol. 2024;200:283-305. doi: 10.1016/B978-0-12-823912-4.00026-8. Handb Clin Neurol. 2024. PMID: 38494283 Review.
Myasthenia gravis (MG) is an autoimmune disease characterized by dysfunction of the neuromuscular junction resulting in skeletal muscle weakness. ...Despite the treatment with symptomatic drugs, steroid-sparing immunosuppressants, intravenous immunoglobuli …
Myasthenia gravis (MG) is an autoimmune disease characterized by dysfunction of the neuromuscular junction resulting in skelet …
International consensus guidance for management of myasthenia gravis: Executive summary.
Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M, Palace J, Richman DP, Verschuuren J, Narayanaswami P. Sanders DB, et al. Neurology. 2016 Jul 26;87(4):419-25. doi: 10.1212/WNL.0000000000002790. Epub 2016 Jun 29. Neurology. 2016. PMID: 27358333 Free PMC article. Review.
OBJECTIVE: To develop formal consensus-based guidance for the management of myasthenia gravis (MG). METHODS: In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 int …
OBJECTIVE: To develop formal consensus-based guidance for the management of myasthenia gravis (MG). METHODS: In October 2013, …
Guideline for the management of myasthenic syndromes.
Wiendl H, Abicht A, Chan A, Della Marina A, Hagenacker T, Hekmat K, Hoffmann S, Hoffmann HS, Jander S, Keller C, Marx A, Melms A, Melzer N, Müller-Felber W, Pawlitzki M, Rückert JC, Schneider-Gold C, Schoser B, Schreiner B, Schroeter M, Schubert B, Sieb JP, Zimprich F, Meisel A. Wiendl H, et al. Ther Adv Neurol Disord. 2023 Dec 26;16:17562864231213240. doi: 10.1177/17562864231213240. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 38152089 Free PMC article. Review.
Myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS), and congenital myasthenic syndromes (CMS) represent an etiologically heterogeneous group of (very) rare chronic diseases. ...Applying MG-specific scores and classifications such as Myasthenia …
Myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS), and congenital myasthenic syndromes (CMS) represent an etiol …
Immune Checkpoint Inhibitor-induced Myositis.
Jayan A, Mammen AL, Suarez-Almazor ME. Jayan A, et al. Rheum Dis Clin North Am. 2024 May;50(2):281-290. doi: 10.1016/j.rdc.2024.02.003. Epub 2024 Mar 12. Rheum Dis Clin North Am. 2024. PMID: 38670726 Free PMC article. Review.
Patients can present with clinical manifestation symptoms of myositis alone or in combination with myocarditis and/or myasthenia gravis, which significantly worsens the course and prognosis. Diagnosis can generally be made on the basis of clinical presentation, elev …
Patients can present with clinical manifestation symptoms of myositis alone or in combination with myocarditis and/or myasthenia g …
Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease.
Vakrakou AG, Karachaliou E, Chroni E, Zouvelou V, Tzanetakos D, Salakou S, Papadopoulou M, Tzartos S, Voumvourakis K, Kilidireas C, Giannopoulos S, Tsivgoulis G, Tzartos J. Vakrakou AG, et al. Front Immunol. 2023 Jul 26;14:1212757. doi: 10.3389/fimmu.2023.1212757. eCollection 2023. Front Immunol. 2023. PMID: 37564637 Free PMC article. Review.
Muscle-specific kinase (MuSK) Myasthenia Gravis (MG) represents a prototypical antibody-mediated disease characterized by predominantly focal muscle weakness (neck, facial, and bulbar muscles) and fatigability. ...In MuSK-MG, classical treatment options are usually …
Muscle-specific kinase (MuSK) Myasthenia Gravis (MG) represents a prototypical antibody-mediated disease characterized by pred …
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature.
Safa H, Johnson DH, Trinh VA, Rodgers TE, Lin H, Suarez-Almazor ME, Fa'ak F, Saberian C, Yee C, Davies MA, Tummala S, Woodman K, Abdel-Wahab N, Diab A. Safa H, et al. J Immunother Cancer. 2019 Nov 21;7(1):319. doi: 10.1186/s40425-019-0774-y. J Immunother Cancer. 2019. PMID: 31753014 Free PMC article.
BACKGROUND: Myasthenia gravis (MG) is a rare but life-threatening adverse event of immune checkpoint inhibitors (ICI). ...A better outcome was observed in patients who received intravenous immunoglobulin (IVIG) or plasmapheresis (PLEX) as first- …
BACKGROUND: Myasthenia gravis (MG) is a rare but life-threatening adverse event of immune checkpoint inhibitors (ICI). ...A be …
Triple M Overlap Syndrome: Myocarditis, Myositis and Myasthenia Gravis After a Single Administration of Pembrolizumab.
Baptista C, Margarido I, Bizarro R, Branco FP, Faria A. Baptista C, et al. Cureus. 2025 Jan 2;17(1):e76834. doi: 10.7759/cureus.76834. eCollection 2025 Jan. Cureus. 2025. PMID: 39897316 Free PMC article.
Triple M Overlap Syndrome (TMOS) is a rare and severe complication of immune checkpoint inhibitor (ICI) therapy, characterized by concurrent myocarditis, myositis and myasthenia gravis. There is a scarcity of evidence regarding this syndrome, underscoring the need f …
Triple M Overlap Syndrome (TMOS) is a rare and severe complication of immune checkpoint inhibitor (ICI) therapy, characterized by concurrent …
Juvenile myasthenia gravis.
Chiang LM, Darras BT, Kang PB. Chiang LM, et al. Muscle Nerve. 2009 Apr;39(4):423-31. doi: 10.1002/mus.21195. Muscle Nerve. 2009. PMID: 19229875 Review.
Juvenile myasthenia gravis shares a similar pathophysiologic origin with adult myasthenia gravis, but there are important differences, mostly relating to epidemiology, presentation, and therapeutic decision making. ...Therapeutic decisions in affected …
Juvenile myasthenia gravis shares a similar pathophysiologic origin with adult myasthenia gravis, but there are …
Management of immune-related myocarditis, myositis and myasthenia gravis (MMM) overlap syndrome: a single institution case series and literature review.
Sánchez-Camacho A, Torres-Zurita A, Gallego-López L, Hernández-Pacheco R, Silva-Romeiro S, Álamo de la Gala MDC, Peral-Gutiérrez de Ceballos E, de la Cruz-Merino L. Sánchez-Camacho A, et al. Front Immunol. 2025 May 8;16:1597259. doi: 10.3389/fimmu.2025.1597259. eCollection 2025. Front Immunol. 2025. PMID: 40406130 Free PMC article. Review.
One such life-threatening irAE is the myocarditis, myositis, and myasthenia gravis (MMM) overlap syndrome, which occurs in less than 1% of patients but has in-hospital mortality rates ranging from 40 to 60%. ...Therapeutic interventions-including corticosteroids, …
One such life-threatening irAE is the myocarditis, myositis, and myasthenia gravis (MMM) overlap syndrome, which occurs in les …
255 results